{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:17:36Z","timestamp":1790230656959,"version":"4.1.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T00:00:00Z","timestamp":1532563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T00:00:00Z","timestamp":1532563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["Core-to-Core Program, Asia-Africa Science Platforms"],"award-info":[{"award-number":["Core-to-Core Program, Asia-Africa Science Platforms"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["S2802"],"award-info":[{"award-number":["S2802"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16K07346"],"award-info":[{"award-number":["16K07346"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fused in sarcoma (FUS) was identified as a component of typical inclusions in frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). In FTLD, both nuclear and cytoplasmic inclusions with wild-type FUS exist, while cytoplasmic inclusions with a mutant-form of FUS occur in many ALS cases. These observations imply that FUS plays a role across these two diseases. In this study, we examined the effect of several proteins including molecular chaperons on the aberrant eye morphology phenotype induced by overexpression of wild-type human <jats:italic>FUS<\/jats:italic> (<jats:italic>hFUS<\/jats:italic>) in <jats:italic>Drosophila<\/jats:italic> eye imaginal discs. By screening, we found that the co-expression of nucleophosmin\u2013human myeloid leukemia factor 1 (NPM<jats:italic>-<\/jats:italic>hMLF1) fusion protein could suppress the aberrant eye morphology phenotype induced by <jats:italic>hFUS<\/jats:italic>. The driving of <jats:italic>hFUS<\/jats:italic> expression at 28\u2009\u00b0C down-regulated levels of hFUS and endogenous cabeza, a <jats:italic>Drosophila<\/jats:italic> homolog of hFUS. The down-regulation was mediated by proteasome dependent degradation. Co-expression of <jats:italic>NPM<\/jats:italic>-<jats:italic>hMLF<\/jats:italic>1 suppressed this down-regulation. In addition, co-expression of <jats:italic>NPM<\/jats:italic>-<jats:italic>hMLF<\/jats:italic>1 partially rescued pharate adult lethal phenotype induced by <jats:italic>hFUS<\/jats:italic> in motor neurons. These findings with a <jats:italic>Drosophila<\/jats:italic> model that mimics FTLD provide clues for the development of novel FTLD therapies.<\/jats:p>","DOI":"10.1038\/s41598-018-29716-9","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T11:20:56Z","timestamp":1532085656000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["NPM-hMLF1 fusion protein suppresses defects of a Drosophila FTLD model expressing the human FUS gene"],"prefix":"10.1038","volume":"8","author":[{"given":"Itaru","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukie","family":"Kushimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuko","family":"Mizuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2950-7361","authenticated-orcid":false,"given":"Morio","family":"Ueyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Tokuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamitsu","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,26]]},"reference":[{"key":"29716_CR1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41582-018-0009-8","volume":"14","author":"S Van Mossevelde","year":"2018","unstructured":"Van Mossevelde, S., Engelborghs, S., van der Zee, J. & Van Broeckhoven, C. Genotype-phenotype links in frontotemporal lobar degeneration. Nat Rev Neurol 14, 363\u2013378 (2018).","journal-title":"Nat Rev Neurol"},{"key":"29716_CR2","first-page":"646","volume":"25","author":"H Chen","year":"2018","unstructured":"Chen, H., Kankel, M. W., Su, S. C., Han, S. W. S. & Ofengeim, D. Exploring the genetics and non-cell autonomous mechanisms underlying ALS\/FTLD. Cell Death Differ. 25, 646\u2013660 (2018).","journal-title":"Cell Death Differ."},{"key":"29716_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/11586000-000000000-00000","volume":"25","author":"PH Gordon","year":"2011","unstructured":"Gordon, P. H. Amyotrophic lateral sclerosis: pathophysiology, diagnosis and management. CNS Drugs 25, 1\u201315 (2011).","journal-title":"CNS Drugs"},{"key":"29716_CR4","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1212\/WNL.59.7.1077","volume":"59","author":"C Lomen-Hoerth","year":"2002","unstructured":"Lomen-Hoerth, C., Anderson, T. & Miller, B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 59, 1077\u20131079 (2002).","journal-title":"Neurology"},{"key":"29716_CR5","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1212\/01.wnl.0000172911.39167.b6","volume":"65","author":"GM Ringholz","year":"2005","unstructured":"Ringholz, G. M. et al. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 65, 586\u2013590 (2005).","journal-title":"Neurology"},{"key":"29716_CR6","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.cell.2015.01.052","volume":"160","author":"R Guerreiro","year":"2015","unstructured":"Guerreiro, R., Br\u00e1s, J. & Hardy, J. SnapShot: Genetics of ALS and FTD. Cell 160, 798\u2013798.e1 (2015).","journal-title":"Cell"},{"key":"29716_CR7","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nrneurol.2016.111","volume":"12","author":"EV Hobson","year":"2016","unstructured":"Hobson, E. V. & McDermott, C. J. Supportive and symptomatic management of amyotrophic lateral sclerosis. Nat Rev Neurol 12, 526\u2013538 (2016).","journal-title":"Nat Rev Neurol"},{"key":"29716_CR8","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","volume":"390","author":"MA van Es","year":"2017","unstructured":"van Es, M. A. et al. Amyotrophic lateral sclerosis. Lancet 390, 2084\u20132098 (2017).","journal-title":"Lancet"},{"key":"29716_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-009-0612-2","volume":"119","author":"IRA Mackenzie","year":"2010","unstructured":"Mackenzie, I. R. A. et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol 119, 1\u20134 (2010).","journal-title":"Acta Neuropathol"},{"key":"29716_CR10","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1093\/brain\/awp214","volume":"132","author":"M Neumann","year":"2009","unstructured":"Neumann, M. et al. A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 132, 2922\u20132931 (2009).","journal-title":"Brain"},{"key":"29716_CR11","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00401-009-0581-5","volume":"118","author":"M Neumann","year":"2009","unstructured":"Neumann, M. et al. Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease. Acta Neuropathol. 118, 605\u2013616 (2009).","journal-title":"Acta Neuropathol."},{"key":"29716_CR12","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00401-009-0598-9","volume":"118","author":"DG Munoz","year":"2009","unstructured":"Munoz, D. G. et al. FUS pathology in basophilic inclusion body disease. Acta Neuropathol. 118, 617\u2013627 (2009).","journal-title":"Acta Neuropathol."},{"key":"29716_CR13","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1126\/science.1166066","volume":"323","author":"TJ Kwiatkowski","year":"2009","unstructured":"Kwiatkowski, T. J. et al. Mutations in the FUS\/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 1205\u20131208 (2009).","journal-title":"Science"},{"key":"29716_CR14","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.1165942","volume":"323","author":"C Vance","year":"2009","unstructured":"Vance, C. et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208\u20131211 (2009).","journal-title":"Science"},{"key":"29716_CR15","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1080\/15476286.2016.1211225","volume":"13","author":"F Svetoni","year":"2016","unstructured":"Svetoni, F., Frisone, P. & Paronetto, M. P. Role of FET proteins in neurodegenerative disorders. RNA Biol 13, 1089\u20131102 (2016).","journal-title":"RNA Biol"},{"key":"29716_CR16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1093\/jmcb\/mjp025","volume":"1","author":"AY Tan","year":"2009","unstructured":"Tan, A. Y. & Manley, J. L. The TET family of proteins: functions and roles in disease. J Mol Cell Biol 1, 82\u201392 (2009).","journal-title":"J Mol Cell Biol"},{"key":"29716_CR17","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1038\/emboj.2010.143","volume":"29","author":"D Dormann","year":"2010","unstructured":"Dormann, D. et al. ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J. 29, 2841\u20132857 (2010).","journal-title":"EMBO J."},{"key":"29716_CR18","first-page":"83","volume":"149","author":"C Colombrita","year":"2011","unstructured":"Colombrita, C. et al. RNA-binding proteins and RNA metabolism: a new scenario in the pathogenesis of Amyotrophic lateral sclerosis. Arch Ital Biol 149, 83\u201399 (2011).","journal-title":"Arch Ital Biol"},{"key":"29716_CR19","doi-asserted-by":"publisher","first-page":"e1005357","DOI":"10.1371\/journal.pgen.1005357","volume":"11","author":"J Deng","year":"2015","unstructured":"Deng, J. et al. FUS Interacts with HSP60 to Promote Mitochondrial Damage. PLoS Genet. 11, e1005357 (2015).","journal-title":"PLoS Genet."},{"key":"29716_CR20","doi-asserted-by":"publisher","first-page":"4748","DOI":"10.1093\/hmg\/ddt328","volume":"22","author":"M Sabatelli","year":"2013","unstructured":"Sabatelli, M. et al. Mutations in the 3\u2032 untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis. Hum. Mol. Genet. 22, 4748\u20134755 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"29716_CR21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00401-012-1043-z","volume":"125","author":"JC Mitchell","year":"2013","unstructured":"Mitchell, J. C. et al. Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion. Acta Neuropathol. 125, 273\u2013288 (2013).","journal-title":"Acta Neuropathol."},{"key":"29716_CR22","doi-asserted-by":"publisher","first-page":"e1002011","DOI":"10.1371\/journal.pgen.1002011","volume":"7","author":"C Huang","year":"2011","unstructured":"Huang, C. et al. FUS transgenic rats develop the phenotypes of amyotrophic lateral sclerosis and frontotemporal lobar degeneration. PLoS Genet. 7, e1002011 (2011).","journal-title":"PLoS Genet."},{"key":"29716_CR23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.neuroscience.2014.12.007","volume":"287","author":"H Suzuki","year":"2015","unstructured":"Suzuki, H. & Matsuoka, M. Overexpression of nuclear FUS induces neuronal cell death. Neuroscience 287, 113\u2013124 (2015).","journal-title":"Neuroscience"},{"key":"29716_CR24","doi-asserted-by":"crossref","unstructured":"Shao, J. & Diamond, M. I. Polyglutamine diseases: emerging concepts in pathogenesis and therapy. Hum. Mol. Genet. 16 Spec No. 2, R115\u2013123 (2007).","DOI":"10.1093\/hmg\/ddm213"},{"key":"29716_CR25","doi-asserted-by":"publisher","first-page":"6489","DOI":"10.1074\/jbc.M705306200","volume":"283","author":"H Doi","year":"2008","unstructured":"Doi, H. et al. RNA-binding protein TLS is a major nuclear aggregate-interacting protein in huntingtin exon 1 with expanded polyglutamine-expressing cells. J. Biol. Chem. 283, 6489\u20136500 (2008).","journal-title":"J. Biol. Chem."},{"key":"29716_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.neures.2009.10.004","volume":"66","author":"H Doi","year":"2010","unstructured":"Doi, H., Koyano, S., Suzuki, Y., Nukina, N. & Kuroiwa, Y. The RNA-binding protein FUS\/TLS is a common aggregate-interacting protein in polyglutamine diseases. Neurosci. Res. 66, 131\u2013133 (2010).","journal-title":"Neurosci. Res."},{"key":"29716_CR27","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/j.1750-3639.2009.00337.x","volume":"20","author":"J Woulfe","year":"2010","unstructured":"Woulfe, J., Gray, D. A. & Mackenzie, I. R. A. FUS-immunoreactive intranuclear inclusions in neurodegenerative disease. Brain Pathol. 20, 589\u2013597 (2010).","journal-title":"Brain Pathol."},{"key":"29716_CR28","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1128\/MCB.15.8.4562","volume":"15","author":"D Immanuel","year":"1995","unstructured":"Immanuel, D., Zinszner, H. & Ron, D. Association of SARFH (sarcoma-associated RNA-binding fly homolog) with regions of chromatin transcribed by RNA polymerase II. Mol. Cell. Biol. 15, 4562\u20134571 (1995).","journal-title":"Mol. Cell. Biol."},{"key":"29716_CR29","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/nar\/23.5.835","volume":"23","author":"DT Stolow","year":"1995","unstructured":"Stolow, D. T. & Haynes, S. R. Cabeza, a Drosophila gene encoding a novel RNA binding protein, shares homology with EWS and TLS, two genes involved in human sarcoma formation. Nucleic Acids Res. 23, 835\u2013843 (1995).","journal-title":"Nucleic Acids Res."},{"key":"29716_CR30","doi-asserted-by":"publisher","first-page":"e39483","DOI":"10.1371\/journal.pone.0039483","volume":"7","author":"H Sasayama","year":"2012","unstructured":"Sasayama, H. et al. Knockdown of the Drosophila fused in sarcoma (FUS) homologue causes deficient locomotive behavior and shortening of motoneuron terminal branches. PLoS ONE 7, e39483 (2012).","journal-title":"PLoS ONE"},{"key":"29716_CR31","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1172\/JCI57883","volume":"121","author":"J-W Wang","year":"2011","unstructured":"Wang, J.-W., Brent, J. R., Tomlinson, A., Shneider, N. A. & McCabe, B. D. The ALS-associated proteins FUS and TDP-43 function together to affect Drosophila locomotion and life span. J. Clin. Invest. 121, 4118\u20134126 (2011).","journal-title":"J. Clin. Invest."},{"key":"29716_CR32","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s13238-011-1065-7","volume":"2","author":"Y Chen","year":"2011","unstructured":"Chen, Y. et al. Expression of human FUS protein in Drosophila leads to progressive neurodegeneration. Protein Cell 2, 477\u2013486 (2011).","journal-title":"Protein Cell"},{"key":"29716_CR33","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1093\/hmg\/ddr150","volume":"20","author":"NA Lanson","year":"2011","unstructured":"Lanson, N. A. et al. A Drosophila model of FUS-related neurodegeneration reveals genetic interaction between FUS and TDP-43. Hum. Mol. Genet. 20, 2510\u20132523 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"29716_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1750-1326-7-10","volume":"7","author":"R Xia","year":"2012","unstructured":"Xia, R. et al. Motor neuron apoptosis and neuromuscular junction perturbation are prominent features in a Drosophila model of Fus-mediated ALS. Mol Neurodegener 7, 10 (2012).","journal-title":"Mol Neurodegener"},{"key":"29716_CR35","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1093\/hmg\/ddu094","volume":"23","author":"JB Machamer","year":"2014","unstructured":"Machamer, J. B., Collins, S. E. & Lloyd, T. E. The ALS gene FUS regulates synaptic transmission at the Drosophila neuromuscular junction. Hum. Mol. Genet. 23, 3810\u20133822 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"29716_CR36","doi-asserted-by":"publisher","first-page":"19590","DOI":"10.1523\/JNEUROSCI.3396-13.2013","volume":"33","author":"M Shahidullah","year":"2013","unstructured":"Shahidullah, M. et al. Defects in synapse structure and function precede motor neuron degeneration in Drosophila models of FUS-related ALS. J. Neurosci. 33, 19590\u201319598 (2013).","journal-title":"J. Neurosci."},{"key":"29716_CR37","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.nbd.2014.11.003","volume":"74","author":"S J\u00e4ckel","year":"2015","unstructured":"J\u00e4ckel, S. et al. Nuclear import factor transportin and arginine methyltransferase 1 modify FUS neurotoxicity in. Drosophila. Neurobiol. Dis. 74, 76\u201388 (2015).","journal-title":"Drosophila. Neurobiol. Dis."},{"key":"29716_CR38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.expneurol.2015.08.002","volume":"274","author":"Z Xu","year":"2015","unstructured":"Xu, Z., Tito, A. J., Rui, Y.-N. & Zhang, S. Studying polyglutamine diseases in Drosophila. Exp. Neurol. 274, 25\u201341 (2015).","journal-title":"Exp. Neurol."},{"key":"29716_CR39","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/bs.ctdb.2016.07.006","volume":"121","author":"M Krench","year":"2017","unstructured":"Krench, M. & Littleton, J. T. Neurotoxicity Pathways in Drosophila Models of the Polyglutamine Disorders. Curr. Top. Dev. Biol. 121, 201\u2013223 (2017).","journal-title":"Curr. Top. Dev. Biol."},{"key":"29716_CR40","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.nbd.2006.06.015","volume":"24","author":"Z Fayazi","year":"2006","unstructured":"Fayazi, Z. et al. A Drosophila ortholog of the human MRJ modulates polyglutamine toxicity and aggregation. Neurobiol. Dis. 24, 226\u2013244 (2006).","journal-title":"Neurobiol. Dis."},{"key":"29716_CR41","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1093\/hmg\/11.21.2657","volume":"11","author":"P Kazemi-Esfarjani","year":"2002","unstructured":"Kazemi-Esfarjani, P. & Benzer, S. Suppression of polyglutamine toxicity by a Drosophila homolog of myeloid leukemia factor 1. Hum. Mol. Genet. 11, 2657\u20132672 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"29716_CR42","first-page":"265","volume":"12","author":"N Yoneda-Kato","year":"1996","unstructured":"Yoneda-Kato, N. et al. The t(3;5)(q25.1; q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1. Oncogene 12, 265\u2013275 (1996).","journal-title":"Oncogene"},{"key":"29716_CR43","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1038\/sj.onc.1202711","volume":"18","author":"N Yoneda-Kato","year":"1999","unstructured":"Yoneda-Kato, N., Fukuhara, S. & Kato, J. Apoptosis induced by the myelodysplastic syndrome-associated NPM-MLF1 chimeric protein. Oncogene 18, 3716\u20133724 (1999).","journal-title":"Oncogene"},{"key":"29716_CR44","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1002\/j.1460-2075.1987.tb02447.x","volume":"6","author":"MS Schmidt-Zachmann","year":"1987","unstructured":"Schmidt-Zachmann, M. S., H\u00fcgle-D\u00f6rr, B. & Franke, W. W. A constitutive nucleolar protein identified as a member of the nucleoplasmin family. EMBO J. 6, 1881\u20131890 (1987).","journal-title":"EMBO J."},{"key":"29716_CR45","doi-asserted-by":"publisher","first-page":"9708","DOI":"10.1021\/bi00493a028","volume":"29","author":"CF Semenkovich","year":"1990","unstructured":"Semenkovich, C. F., Ostlund, R. E., Olson, M. O. & Yang, J. W. A protein partially expressed on the surface of HepG2 cells that binds lipoproteins specifically is nucleolin. Biochemistry 29, 9708\u20139713 (1990).","journal-title":"Biochemistry"},{"key":"29716_CR46","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1111\/j.1365-2443.2006.01023.x","volume":"11","author":"S Martin-Lanner\u00e9e","year":"2006","unstructured":"Martin-Lanner\u00e9e, S. et al. Characterization of the Drosophila myeloid leukemia factor. Genes Cells 11, 1317\u20131335 (2006).","journal-title":"Genes Cells"},{"key":"29716_CR47","doi-asserted-by":"publisher","first-page":"5559","DOI":"10.1093\/emboj\/18.20.5559","volume":"18","author":"JH Williams","year":"1999","unstructured":"Williams, J. H. et al. HLS7, a hemopoietic lineage switch gene homologous to the leukemia-inducing gene MLF1. EMBO J. 18, 5559\u20135566 (1999).","journal-title":"EMBO J."},{"key":"29716_CR48","doi-asserted-by":"publisher","first-page":"40997","DOI":"10.1074\/jbc.M206041200","volume":"277","author":"R Lim","year":"2002","unstructured":"Lim, R. et al. MADM, a novel adaptor protein that mediates phosphorylation of the 14-3-3 binding site of myeloid leukemia factor 1. J. Biol. Chem. 277, 40997\u201341008 (2002).","journal-title":"J. Biol. Chem."},{"key":"29716_CR49","first-page":"43","volume":"2","author":"JM Kramer","year":"2003","unstructured":"Kramer, J. M. & Staveley, B. E. GAL4 causes developmental defects and apoptosis when expressed in the developing eye of Drosophila melanogaster. Genet. Mol. Res. 2, 43\u201347 (2003).","journal-title":"Genet. Mol. Res."},{"key":"29716_CR50","doi-asserted-by":"publisher","first-page":"15962","DOI":"10.1523\/JNEUROSCI.2526-14.2014","volume":"34","author":"AN Coyne","year":"2014","unstructured":"Coyne, A. N. et al. Futsch\/MAP1B mRNA is a translational target of TDP-43 and is neuroprotective in a Drosophila model of amyotrophic lateral sclerosis. J. Neurosci. 34, 15962\u201315974 (2014).","journal-title":"J. Neurosci."},{"key":"29716_CR51","doi-asserted-by":"publisher","first-page":"e1003895","DOI":"10.1371\/journal.pgen.1003895","volume":"9","author":"Y Zhou","year":"2013","unstructured":"Zhou, Y., Liu, S., Liu, G., Ozt\u00fcrk, A. & Hicks, G. G. ALS-associated FUS mutations result in compromised FUS alternative splicing and autoregulation. PLoS Genet. 9, e1003895 (2013).","journal-title":"PLoS Genet."},{"key":"29716_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5335","volume":"5","author":"S Dini Modigliani","year":"2014","unstructured":"Dini Modigliani, S., Morlando, M., Errichelli, L., Sabatelli, M. & Bozzoni, I. An ALS-associated mutation in the FUS 3\u2032-UTR disrupts a microRNA-FUS regulatory circuitry. Nat Commun 5, 4335 (2014).","journal-title":"Nat Commun"},{"key":"29716_CR53","doi-asserted-by":"publisher","first-page":"4258","DOI":"10.1038\/emboj.2012.261","volume":"31","author":"D Dormann","year":"2012","unstructured":"Dormann, D. et al. Arginine methylation next to the PY-NLS modulates Transportin binding and nuclear import of FUS. EMBO J. 31, 4258\u20134275 (2012).","journal-title":"EMBO J."},{"key":"29716_CR54","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.mcn.2013.03.006","volume":"56","author":"D Dormann","year":"2013","unstructured":"Dormann, D. & Haass, C. Fused in sarcoma (FUS): an oncogene goes awry in neurodegeneration. Mol. Cell. Neurosci. 56, 475\u2013486 (2013).","journal-title":"Mol. Cell. Neurosci."},{"key":"29716_CR55","doi-asserted-by":"publisher","first-page":"e1006932","DOI":"10.1371\/journal.pgen.1006932","volume":"13","author":"M Miller","year":"2017","unstructured":"Miller, M. et al. Control of RUNX-induced repression of Notch signaling by MLF and its partner DnaJ-1 during Drosophila hematopoiesis. PLoS Genet. 13, e1006932 (2017).","journal-title":"PLoS Genet."},{"key":"29716_CR56","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1016\/j.jmb.2016.10.026","volume":"429","author":"JO Dyer","year":"2017","unstructured":"Dyer, J. O. et al. Myeloid leukemia factor acts in a chaperone complex to regulate transcription factor stability and gene expression. J. Mol. Biol. 429, 2093\u20132107 (2017).","journal-title":"J. Mol. Biol."},{"key":"29716_CR57","doi-asserted-by":"publisher","first-page":"4986","DOI":"10.1073\/pnas.1117317109","volume":"109","author":"S Bras","year":"2012","unstructured":"Bras, S. et al. Myeloid leukemia factor is a conserved regulator of RUNX transcription factor activity involved in hematopoiesis. Proc. Natl. Acad. Sci. USA 109, 4986\u20134991 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"29716_CR58","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1089\/ars.2012.4984","volume":"20","author":"SK Dhar","year":"2014","unstructured":"Dhar, S. K. et al. FUsed in sarcoma is a novel regulator of manganese superoxide dismutase gene transcription. Antioxid. Redox Signal. 20, 1550\u20131566 (2014).","journal-title":"Antioxid. Redox Signal."},{"issue":"Suppl 1","key":"29716_CR59","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/jnc.13625","volume":"138","author":"A Ratti","year":"2016","unstructured":"Ratti, A. & Buratti, E. Physiological functions and pathobiology of TDP-43 and FUS\/TLS proteins. J. Neurochem. 138(Suppl 1), 95\u2013111 (2016).","journal-title":"J. Neurochem."},{"key":"29716_CR60","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann, M. et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130\u2013133 (2006).","journal-title":"Science"},{"key":"29716_CR61","doi-asserted-by":"publisher","first-page":"26042","DOI":"10.1074\/jbc.273.40.26042","volume":"273","author":"T Sawado","year":"1998","unstructured":"Sawado, T. et al. The DNA replication-related element (DRE)\/DRE-binding factor system is a transcriptional regulator of the Drosophila E2F gene. J. Biol. Chem. 273, 26042\u201326051 (1998).","journal-title":"J. Biol. Chem."},{"key":"29716_CR62","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/nar\/27.2.510","volume":"27","author":"Y Takahashi","year":"1999","unstructured":"Takahashi, Y., Hirose, F., Matsukage, A. & Yamaguchi, M. Identification of three conserved regions in the DREF transcription factors from Drosophila melanogaster and Drosophila virilis. Nucleic Acids Res. 27, 510\u2013516 (1999).","journal-title":"Nucleic Acids Res."},{"key":"29716_CR63","doi-asserted-by":"publisher","first-page":"e0157823","DOI":"10.1371\/journal.pone.0157823","volume":"11","author":"M Nakazawa","year":"2016","unstructured":"Nakazawa, M. et al. The Human Bcl-2 family member Bcl-rambo localizes to mitochondria and induces apoptosis and morphological aberrations in Drosophila. PLoS ONE 11, e0157823 (2016).","journal-title":"PLoS ONE"},{"key":"29716_CR64","first-page":"673","volume":"7","author":"T Umegawachi","year":"2017","unstructured":"Umegawachi, T. et al. Control of tissue size and development by a regulatory element in the yorkie 3\u2032UTR. Am J Cancer Res 7, 673\u2013687 (2017).","journal-title":"Am J Cancer Res"},{"key":"29716_CR65","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.neuron.2017.02.046","volume":"94","author":"T Ishiguro","year":"2017","unstructured":"Ishiguro, T. et al. Regulatory Role of RNA chaperone TDP-43 for RNA misfolding and repeat-associated translation in SCA31. Neuron 94, 108\u2013124.e7 (2017).","journal-title":"Neuron"},{"key":"29716_CR66","doi-asserted-by":"crossref","unstructured":"Griciuc, A. et al. Inactivation of VCP\/ter94 suppresses retinal pathology caused by misfolded rhodopsin in Drosophila. PLoS Genet. 6 (2010).","DOI":"10.1371\/journal.pgen.1001075"},{"key":"29716_CR67","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1242\/dmm.023382","volume":"9","author":"S Langellotti","year":"2016","unstructured":"Langellotti, S. et al. A novel Drosophila model of TDP-43 proteinopathies: N-terminal sequences combined with the Q\/N domain induce protein functional loss and locomotion defects. Dis Model Mech 9, 659\u2013669 (2016).","journal-title":"Dis Model Mech"},{"key":"29716_CR68","first-page":"5059","volume":"25","author":"Y Chen","year":"2016","unstructured":"Chen, Y. et al. PINK1 and Parkin are genetic modifiers for FUS-induced neurodegeneration. Hum. Mol. Genet. 25, 5059\u20135068 (2016).","journal-title":"Hum. Mol. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29716-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29716-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29716-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T07:42:45Z","timestamp":1671608565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29716-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,26]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["29716"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-29716-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,26]]},"assertion":[{"value":"24 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11291"}}